PRECIGEN, INC. Machinery and Equipment, Gross
PRECIGEN, INC. (PGEN) had Machinery and Equipment, Gross of $19.89 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:MachineryAndEquipmentGross · last filed 2026-08-04
- 2026-06-30: Machinery and Equipment, Gross $19.89M.
- 2026-03-31: Machinery and Equipment, Gross $19.68M.
- 2025-12-31: Machinery and Equipment, Gross $19.44M.
- 2025-09-30: Machinery and Equipment, Gross $19.27M.
| Period end | Machinery and Equipment, Gross | Machinery and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $19.89M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $19.68M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $19.44M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $19.27M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $16.75M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $16.77M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $16.77M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $16.77M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $16.63M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $18.53M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $18.58M 10-K · filed 2025-03-19 | |
| 2023-09-30 | $18.45M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $18.54M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $18.43M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $18.01M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $17.69M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $17.57M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $34.30M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $16.81M 10-K · filed 2023-03-06 | $33.58M 10-K · filed 2022-03-01 |
| 2021-09-30 | $32.63M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $32.07M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $31.54M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $31.15M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $48.03M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $47.46M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $52.50M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $33.71M 10-K · filed 2021-03-01 | $54.45M 10-K · filed 2020-03-02 |
| 2019-09-30 | $67.02M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $68.14M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $76.72M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $63.95M 10-K · filed 2020-03-02 | $74.56M 10-K · filed 2019-03-01 |
| 2018-09-30 | $72.13M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $70.47M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $69.57M 10-Q/A · filed 2018-08-13 | |
| 2017-12-31 | $65.86M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $58.85M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $56.53M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $46.34M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $44.39M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $41.34M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $40.31M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $37.37M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $36.02M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $36.02M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $34.49M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $33.05M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $31.98M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $31.18M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $24.30M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $24.20M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $22.27M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $22.04M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $22.85M 10-Q/A · filed 2013-10-21 | |
| 2012-12-31 | $22.20M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |